NewLink Genetics Corporation (NASDAQ:NLNK) announced that data from two Phase 2 studies of indoximod, used in combination with other agents, were presented at ASCO 2018 Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
BioIVT will be hosting a webinar entitled “Whole-cell In Vitro Models Can Predict Clinically-relevant Herb-Drug Interactions (HDIs)” at 11 am ET on June 20. Read More
Asymmetrex founder and director James Sherley addresses the importance and challenges of introducing stem cell dose standardization into regenerative medicine practice. Read More
Landos Biopharma presents findings for its lead candidate, BT-11, at Digestive Disease Week Read More
Stem cell biotechnology company Asymmetrex and preclinical toxicology CRO DRIK have formed a new partnership for addressing a significant unmet need in the pharmaceutical and cell therapy industries. Read More